China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on Whether Patients with iMCD Can Safely Stop TCP Treatment After Remission'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133598
Registration Time: 2026/09/29
Type: Observational study
Primary Sponsor: Peking Union Medical College Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344977
Published by HT Digital Content Services with permission from Health Daily Digest....